PIK3CA and head and neck squamous cell carcinoma: Previous studies of Tian et al. with the inhibitor BEZ235 (dual inhibitor of PI3K-mTOR) loaded in delivery systems, such as liposomes, significantly reduced the cell viability of the HN5 head and neck squamous cell carcinoma cell line compared with the control and inhibitor alone at 72 h [28].